Kexing Biopharm Co., Ltd. (SHA:688136)
China flag China · Delayed Price · Currency is CNY
46.81
+0.33 (0.71%)
Aug 8, 2025, 2:45 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
Eprodin
608.06M
Log In
Log In
Log In
Log In
Upgrade
Eprodin Growth
-15.73%
Log In
Log In
Log In
Log In
Upgrade
Serokin
310.63M
Log In
Log In
Log In
Log In
Upgrade
Serokin Growth
12.49%
Log In
Log In
Log In
Log In
Upgrade
Bai Texi
146.10M
Log In
Log In
Log In
Log In
Upgrade
Bai Texi Growth
-18.88%
Log In
Log In
Log In
Log In
Upgrade
Chang Le Kang
142.80M
Log In
Log In
Log In
Log In
Upgrade
Chang Le Kang Growth
16.90%
Log In
Log In
Log In
Log In
Upgrade
Other Business
49.90M
Log In
Log In
Log In
Log In
Upgrade
Other Business Growth
215.01%
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Recombinant Human Erythropoietin
-
Log In
Log In
Log In
Log In
Upgrade
Recombinant Human Erythropoietin Growth
-
Log In
Log In
Log In
Log In
Upgrade
Recombinant Human Interfon a1b
-
Log In
Log In
Log In
Log In
Upgrade
Recombinant Human Interfon a1b Growth
-
Log In
Log In
Log In
Log In
Upgrade
Recombinant Human Granulocyte Stimulating Factor
-
Log In
Log In
Log In
Log In
Upgrade
Recombinant Human Granulocyte Stimulating Factor Growth
-
Log In
Log In
Log In
Log In
Upgrade
Live Clostridium Butyricum
-
Log In
Log In
Log In
Log In
Upgrade
Live Clostridium Butyricum Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192017 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
China
1.26B
Log In
Log In
Log In
Log In
Upgrade
China Growth
-4.32%
Log In
Log In
Log In
Log In
Upgrade